295 results
Page 8 of 15
8-K
EX-99.1
wcpe8lsytt
27 Aug 12
Other Events
12:00am
8-K
EX-99.1
84cg62figad9f
16 Aug 12
BioTime and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers
12:00am
8-K
EX-99.1
0gl9e0h40y
9 Aug 12
BioTime Announces Second Quarter 2012 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
1jztz
1 Aug 12
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.33 Million Grant From Israel’s Office of the Chief Scientist
12:00am
8-K
EX-99.1
hg2kheozme
26 Jul 12
BioTime Subsidiary LifeMap Sciences, Inc. Announces Financing of Up to $3 Million from Share Exchange Agreement
12:00am
8-K
EX-99.1
yfdvaag am
17 Jul 12
BioTime Signs Agreements with Jade Therapeutics for Ophthalmological Drug Delivery Applications of HyStem® Technology
12:00am
DEFA14A
qugtqljpntk8cei5 zu
5 Jun 12
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
sgmu7ln 7o6
23 May 12
BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards® Version 3.08
12:00am
8-K
EX-99.1
q65todt1z9bwwdy
22 May 12
BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human Diseases
12:00am
8-K
EX-99.1
aqmh3v
21 May 12
Unregistered Sales of Equity Securities
12:00am
8-K
EX-99.1
pmy784yu
14 May 12
Regulation FD Disclosure
12:00am
8-K
phn87
25 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.4
m75f002lv2vt
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.6
ycglw2fu
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.2
ltvm6t
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am
8-K
EX-99.5
c52yvu357gwjgq r4ia5
23 Apr 12
BioTime Provides Update on ReneviaTM Product Development
12:00am